youtube_live
Q1 2026 daromadi • nashr etilgan • Aksiya boʻyicha daromad kutilganidan past -16,82% • Daromad kutilganidan past -1,86%
Natijalarini ochishchevron_right
OGN:NYSE
Organon & Co
13,25 US$
arrow_downward
-0,67%(-0,090) 1K
13,25 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 30-apr, 16:01:12 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoOGN tikeri uchun statistika yaratilmoqda...
Ochish
13,32 US$
Yuqori
13,39 US$
Past
13,25 US$
Bozor kapitali
3,48 mlrd
Oʻrtacha hajm
6,21 mln
Hajmi
0,00
Dividend
0,60%
Choraklik dividendlar
0,02 US$
Eks-dividend sanasi
20-noy, 2025
P/E koeffitsiyenti
18,48
52 haftalik eng yuqori
13,39 US$
52 haftalik eng past
5,69 US$
Aksiya boʻyicha daromad
0,72 US$
Beta
0,66
Muomaladagi aksiyalar
262,60 mln
Xodimlar soni
10 ming
Yangiliklar
Internetdagi manbalardan
The Financial World
·
3 soat oldin
Sun Pharma to acquire Organon for Inorganic Growth
Simply Wall Street
·
5 soat oldin
Organon (OGN) Margin Hit To 3% Tests Bullish Earnings Recovery Story
Yahoo Finance
·
8 soat oldin
Organon (NYSE:OGN) Misses Q1 CY2026 Revenue Estimates
Stock Titan
·
15 soat oldin
Vanguard Capital Management reports 13.7M shares in Organon (OGN)
Profil
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Organon & Co haqida
CEO-
Xodimlar soni10 ming
Asos solingan1923
Bosh ofislarJersey City, N'yu-Jersi, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytorganon.com
AI kontentda xatolar boʻlishi mumkin. Batafsil